Copyright
©The Author(s) 2016.
World J Clin Infect Dis. Nov 25, 2016; 6(4): 67-72
Published online Nov 25, 2016. doi: 10.5495/wjcid.v6.i4.67
Published online Nov 25, 2016. doi: 10.5495/wjcid.v6.i4.67
Table 1 Serological profile for anti-Mycoplasma pneumoniae antibodies in patients with of lower respiratory airway infections
Anti-Mycoplasma pneumoniae antibodies profiles | Patients | ||||
Group | IgG | IgM | IgA | n (%) | 95%CI |
A | Negative | Negative | Negative | 821 (76.9%) | 74.37-79.43 |
B | Positive | Negative | Negative | 143 (13.4%) | 11.36-15.44 |
C | Negative | Positive | Negative | 40 (3.7%) | 2.57-4.83 |
D | Negative | Negative | Positive | 21 (2.0%) | 1.16-2.84 |
E | Positive | Positive | Negative | 13 (1.2%) | 0.55-1.85 |
F | Positive | Negative | Positive | 16 (1.5%) | 0.77-2.23 |
G | Negative | Positive | Positive | 7 (0.7%) | 0.20-1.20 |
H | Positive | Positive | Positive | 6 (0.6%) | 0.14-1.06 |
- Citation: De Paschale M, Cerulli T, Cagnin D, Paganini A, Manco MT, Belvisi L, Morazzoni C, Marinoni L, Agrappi C, Mirri P, Clerici P. Can the detection of IgA anti-Mycoplasma pneumoniae added to IgM increase diagnostic accuracy in patients with infections of the lower respiratory airways? World J Clin Infect Dis 2016; 6(4): 67-72
- URL: https://www.wjgnet.com/2220-3176/full/v6/i4/67.htm
- DOI: https://dx.doi.org/10.5495/wjcid.v6.i4.67